Poland· PL-100348674

AuroValsart

A valsartan product containing valsartanum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.

ATC C09CA03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAuroValsartATCC09CA03REGISTER NO.PL-100348674PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Valsartan is registered in 19 of 19 countries.

Countries holding a registration under ATC C09CA03 (valsartan), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose

Valsartan · ATC C09CA03

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valsartan costs, country by country.

Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.14 in France to $0.56 in Switzerland — a ×4.1 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Valsartan · price per daily dose (80 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.56
  • IT Italy$0.15
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Valsartanum
Manufacturer
Aurovitas Pharma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
C09CA03
ATC class
Valsartan
Defined daily dose
80 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991345778
  • gtin
    05909991345785
  • gtin
    05909991345792

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

421 interactions on record for valsartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Valsartan · interactions on record

421 records

  • 7 severe
  • 128 moderate
  • 205 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valsartan in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valsartan products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Diovan, Valsacor
  • Belgium · Diovane, Valsartan Eg
  • Bulgaria · Suvartar, Валдипин
  • Cyprus · Codaval, Diovan
  • Czechia · Blessin, Diovan
  • Germany · Diovan, Diovan Forte
  • Denmark · Diovan, Valhelen
  • Estonia · Diovan, Valsacor
  • Spain · Diován, Diován Cardio
  • Finland · Diovan, Valsarstad
  • France · Tareg, Valsartan Arrow Lab
  • United Kingdom (Northern Ireland) · Diovan, Valsartan
  • Greece · Avalsan, Diosartan
  • Croatia · Diovan, Val
  • Hungary · Diovan, Tensart
  • Ireland · Diovan, Valsartan Krka
  • Iceland · Diovan, Docartan
  • Italy · Alsartir, Pressloval
  • Lithuania · Diovan, Suvartar
  • Luxembourg · Diovane, Valsartan Eg
  • Latvia · Diovan, Valsacor
  • Malta · Diovan, Valsaben
  • Netherlands · Diovan, Exsartz
  • Norway · Diovan, Valsartan Actavis
  • Portugal · Diovan, Valsartan Alter
  • Romania · Diovan, Valsacor
  • Sweden · Angiosan, Diovan
  • Slovenia · Diovan, Valsacor
  • Slovakia · Diovan, Valsacor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/136a1983-41a8-4a21-b85a-b6c35b65cd3b
GET /v1/drugs/136a1983-41a8-4a21-b85a-b6c35b65cd3b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "80 mg",
  "packaging": "05909991345778 ¦ Rp ¦ 124498\n14 tabl.\n05909991345785 ¦ Rp ¦ 124499\n28 tabl.\n05909991345792 ¦ Rp ¦ 124500\n56 tabl.",
  "substance": "Valsartanum 80 mg",
  "common_name": "Valsartanum",
  "pl_product_id": "100348674",
  "pozwolenie_nr": "24275",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about valsartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.